Á lódáil...
Anti-CD20 monoclonal antibodies: reviewing a revolution
Since the inception of rituximab in the 1990s, anti-CD20 monoclonal antibodies have revolutionised the treatment of B cell hematological malignancies and have become a cornerstone of modern gold-standard practice. Additionally, the potent efficacy of these agents in depleting the B cell compartment...
Na minha lista:
| Foilsithe in: | Hum Vaccin Immunother |
|---|---|
| Main Authors: | , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
Taylor & Francis
2018
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6343614/ https://ncbi.nlm.nih.gov/pubmed/30096012 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2018.1508624 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|